Drug intelligence / Profile preview

composite amniotic gel

Development stage
Preclinical
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Topical, Injectable, Ophthalmic, Surgical Implant, Intraarticular, Intrauterine, Intravesical, Intravaginal, Intradental
01

Overview

Composite amniotic gel refers to a biomaterial derived from human amniotic membrane (AM), often processed into a decellularized and sometimes temperature-sensitive hydrogel form. These hydrogels are designed for regenerative medicine applications due to their unique biological properties, including low immunogenicity, anti-inflammatory effects, anti-fibrotic activity, antibacterial action, and the ability to promote angiogenesis. The mechanism of action is primarily through providing a bioactive extracellular matrix rich in collagen, fibronectin, hyaluronic acid, growth factors (such as EGF, KGF), cytokines (including interleukin-1 receptor antagonist), and other proteins that support tissue repair and modulate inflammation. Composite amniotic gels are used or under investigation for skin repair/wound healing (including diabetic ulcers), cartilage regeneration, heart tissue repair post-infarction or injury, dental pulp regeneration, vascular grafts/repair applications, endometrium regeneration in gynecology/fertility contexts, corneal healing in ophthalmology (e.g., chemical burns or perforations when corneal tissue is unavailable), bone defect repair after surgery or trauma reconstruction procedures such as vaginoplasty or urinary bladder reconstruction[1][2][3][4]. These products can be applied topically as gels/hydrogels or injected for minimally invasive therapies.

Other names
composite amniotic hydrogeldecellularized amnion-derived hydrogeldAM hydrogel

Beyond the preview

Go deeper on composite amniotic gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on composite amniotic gel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call